As Russian Market Goes Dark, U.S. ETFs Show Extent of Damage
(Bloomberg) -- With Russia's stock market closed, U.S. exchange-traded funds are signaling the scale of the rout facing the nation's equity market.
The VanEck Russia ETF (ticker RSX) and the iShares MSCI Russia Capped ETF (ERUS) plunged 30% and 27%, respectively, in U.S. trading Monday. Millions have poured into the funds in the past week, some of which was likely create-to-lend activity in which new shares are created for short sellers to borrow and bet against.
The Bank of Russia halted trading in Moscow on Monday, one of several measures unleashed in a bid to shield the nation's economy from sweeping sanctions. That has turned the two ETFs, which primarily track Russian energy stocks, into useful price-discovery tools for traders seeking to navigate the geopolitical turmoil caused by Russia's invasion of Ukraine.
“The ETF has proven itself time and time again, especially around geopolitical events when liquidity is difficult to access,” said Athanasios Psarofagis, a Bloomberg Intelligence ETF analyst who noted that the ETFs predicted moves last week in Russia's markets. “ETFs are suppose to be index trackers, but when that process breaks down, they take on the role of price-discovery vehicles -- and it's impressive how accurate they have been.”
Russian Stocks Plummet in London With Moscow Exchange Shut
RSX and ERUS have plunged nearly 60% in 2022 as geopolitical risks build, ranking them as the two worst-performing non-leveraged U.S.-listed ETFs so far this year, according to data compiled by Bloomberg. The losses have accelerated in the past week in the face of mounting sanctions, with the U.S. banning transactions with Russia's central bank, the Russian National Wealth Fund and the Ministry of Finance.
The funds took another leg lower Monday after the Bank of Russia announced that stock trading in Moscow will be suspended on Tuesday as well.
The drop for the Russia-tracking ETFs is reminiscent of March 2020, when fixed-income funds continued to trade even as cash markets effectively froze amid pandemic-fueled turmoil.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.